(Q51061495)

English

NY-ESO-1 is a sensitive and specific immunohistochemical marker for myxoid and round cell liposarcomas among related mesenchymal myxoid neoplasms.

scientific article published on 19 April 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23599152

NY-ESO-1 is a sensitive and specific immunohistochemical marker for myxoid and round cell liposarcomas among related mesenchymal myxoid neoplasms. (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23599152

immunohistochemistry

1 reference

based on heuristic

inferred from title

author name string

Jessica A Hemminger

1

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23599152

O Hans Iwenofu

2

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23599152

publication date

19 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23599152

Modern Pathology

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23599152

26

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23599152

9

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23599152

1204-1210

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23599152

Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: An analysis of 26,758 cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.65

21 January 2018

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.65

21 January 2018

Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.65

21 January 2018

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.65

21 January 2018

Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.65

21 January 2018

NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.65

21 January 2018

Genomic cloning and localization of CTAG, a gene encoding an autoimmunogenic cancer-testis antigen NY-ESO-1, to human chromosome Xq28

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.65

21 January 2018

Cancer/testis-associated genes: identification, expression profile, and putative function

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.65

21 January 2018

Cancer/testis antigen expression in human mesenchymal stem cells: down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.65

21 January 2018

Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.65

21 January 2018

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.65

21 January 2018

Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.65

21 January 2018

Cancer/testis (CT) antigens: potential targets for immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.65

21 January 2018

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.65

21 January 2018

NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.65

21 January 2018

Cancer testis antigen expression in gastrointestinal stromal tumors: new markers for early recurrence

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.65

21 January 2018

Intertumor and intratumor NY-ESO-1 expression heterogeneity is associated with promoter-specific and global DNA methylation status in ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.65

21 January 2018

Chromosome X-encoded cancer/testis antigens show distinctive expression patterns in developing gonads and in testicular seminoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.65

7 January 2021

based on heuristic

inferred from DOI database lookup

The cancer-testis antigen NY-ESO-1 is highly expressed in myxoid and round cell subset of liposarcomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.65

7 January 2021

based on heuristic

inferred from DOI database lookup

NY-ESO-1 expression in hepatocellular carcinoma: A potential new marker for early recurrence after surgery

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.65

7 January 2021

based on heuristic

inferred from DOI database lookup

Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.65

7 January 2021

based on heuristic

inferred from DOI database lookup

NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.65

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/MODPATHOL.2013.65

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23599152

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/23599152

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51061495&oldid=2210675501"